GlaxoSmithKline
GSK
$34.90
Share price
-0.43%
Change (1 day)
-19.27%
Change (1 year)
Categories
GlaxoSmithKline (GSK) Fails to deliver data
Key failure to deliver metrics for GlaxoSmithKline:
- Last SEC data release: 2023-02-28
- Last 15 days FTD volume: $0.18 M
- Last 3 months FTD volume: $27.64 M
- Last year FTD volume: $72.38 M
Failures to deliver for GlaxoSmithKline (GSK) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022
Volume in USD (price x number of shares), data since 2022GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $19 M | -64.4% |
| 2022 | $53.37 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Novartis NVS | $3.93 M | $0.10 B | 🇨🇭 Switzerland |
 Pfizer PFE | $0.23 B | $0.56 B | 🇺🇸 USA |
 Sanofi SNY | $38.16 M | $0.11 B | 🇫🇷 France |
 Merck MRK | $0.24 B | $0.58 B | 🇺🇸 USA |
 AstraZeneca AZN | $0.11 B | $0.25 B | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $3.71 M | $35.54 M | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $7.94 M | $66.18 M | 🇺🇸 USA |